2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Genitourinary
1
Dermatologic
1
Conditions
Breast Neoplasms
45
Uterine Cervical Neoplasms
10
Melanoma
10
Endometrial Neoplasms
9
Mouth Neoplasms
6
Squamous Cell Carcinoma of Head and Neck
5
Carcinoma, Intraductal, Noninfiltrating
4
Vulvar Neoplasms
3
Triple Negative Breast Neoplasms
3
Rectal Neoplasms
3
Uterine Neoplasms
2
Ovarian Neoplasms
2
Neoplasm Micrometastasis
2
Neoplasm Metastasis
2
Lymphatic Metastasis
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Head and Neck Neoplasms
2
Eccrine Porocarcinoma
2
Colorectal Neoplasms
2
Colonic Neoplasms
2
Breast Neoplasms, Male
2
Breast Carcinoma In Situ
2
Anus Neoplasms
2
Waldenstrom Macroglobulinemia
1
Sentinel Lymph Node Biopsy (SLNB)
1
Sentinel Lymph Node
1
Sarcoidosis, Pulmonary
1
Sarcoidosis
1
Rhabdomyosarcoma
1
Recurrence
1
Interventions
Cisplatin
6
pembrolizumab
5
fludarabine
5
Nivolumab
5
Cyclophosphamide
5
aldesleukin
4
Paclitaxel
4
Magnetic Resonance Spectroscopy
4
Ifosfamide
4
Radiotherapy
3
Ipilimumab
3
fludarabine phosphate
2
entinostat
2
cabozantinib
2
avelumab
2
aflibercept
2
Specimen Handling
2
CTLA-4 Antigen
2
Biopsy
2
Adoptive Transfer
2
vinflunine
1
toripalimab
1
rocakinogene sifuplasmid
1
ripretinib
1
oncogene protein E7, Human papillomavirus type 16
1
niraparib
1
nimotuzumab
1
lenvatinib
1
enfortumab vedotin
1
durvalumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Penile Neoplasms
×
Sentinel Lymph Node Biopsy
×
Clear all
NCT06666634
2024-10-30
NANOSCAN
The Netherlands Cancer Institute
Phase NA
Recruiting
29 enrolled